The presense or altered level of a specific molecule or biomarker can help to confirm a particular disease state. The ability to detect and quantifiably compare levels of disease markers can yield great insight for the study of diseases and the development of treatments.

Signosis provides a variety of ELISA kits to detect biomarkers for autoimmune, cardiac, and tumor diseases. With the tools, certain diseases can be detected more efficiently.